Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Pulse Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 44 | 1 | 31 | −12 |
| Shares | 3.07M | 65 | 2.44M | −624.4K (−20.4%) |
| Value | $4.66M | $0 | $5.61M | +$952.4K (+20.5%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Pulse Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Spotlight Asset Group, Inc. | 66,425 | $147.0K | 0.15% |
| Group One Trading, L.P. | 2,742 | $6.00K | 0.00% |
| Osterweis Capital Management Inc | 1,000 | $2.00K | 0.00% |
Sold out (15)
Institutions that held Pulse Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 63,401 | $97.0K |
| First Republic Investment Management, Inc. | 48,000 | $73.0K |
| Occudo Quantitative Strategies LP | 58,383 | $54.0K |
| D. E. Shaw & Co., Inc. | 31,827 | $49.0K |
| Schonfeld Strategic Advisors LLC | 26,300 | $40.0K |
| Price T Rowe Associates Inc | 17,600 | $27.0K |
| Deutsche Bank AG | 14,919 | $23.0K |
| Goldman Sachs Group Inc | 12,173 | $19.0K |
| Captrust Financial Advisors | 8,311 | $13.0K |
| Tower Research Capital LLC (TRC) | 4,131 | $6.00K |
| Fifth Third Bancorp | 1,146 | $2.00K |
| Simplex Trading, LLC | 1,474 | $2.00K |
| FMR LLC | 176 | $0 |
| New York State Common Retirement Fund | 117 | $0 |
| Credit Suisse AG | 7 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Pulse Biosciences, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Corbenic Partners LLC | 65 | $0 |